Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 22, 2021 for Ashu Farms LLP Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 21, 2021 for Akash Farms LLP Nath Bio-Genes (India) Ltd - 537291 - Board to consider FY21 Results, Dividend & Buyback of Equity Shares on June 24, 2021
Nath Bio-Genes (India) Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on June 24, 2021 to approve the following :1. To consider, approve and take on record Audited Financial Results of the Company for the 4th quarter and year ended March 31, 2021.2. To consider recommendation of Dividend for the year 2020-21, if any subject to Approval of shareholders in ensuing AGM.3. To consider the proposal for buyback of equity shares of the Company, subject to approval of banks and other authorities.The Company has already closed its "Trading Window" under the Code of Conduct for prevention of Insider Trading from March 31, 2021 and it will re-open on June 27, 2021. Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for To Consider And Approve Audited Financial Results For The 4Th Quarter And Financial Year Ended On 31St March 2021.
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/06/2021 ,inter alia, to consider and approve Audited Financial Results for the 4th quarter and Financial year ended 31st March 2021, and to consider Dividend if any, and to consider buy back of equity shares of the Company if any. Nath Bio-Genes (India) Ltd - 537291 - Clarification sought from Nath Bio-Genes (India) Ltd
The Exchange has sought clarification from Nath Bio-Genes (India) Ltd on June 2, 2021, with reference to Movement in Volume.The reply is awaited. Nath Bio-Genes (India) Ltd - 537291 - Clarification On Increase In Volume.
Clarification on Increase in Volume. Nath Bio-Genes (India) Ltd - 537291 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Nath Bio-Genes (India) Ltd has submitted to BSE a copy of Clarification is enclosed. Nath Bio-Genes (India) Ltd - 537291 - Clarification sought from Nath Bio-Genes (India) Ltd
The Exchange has sought clarification from Nath Bio-Genes (India) Ltd on May 18, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the 31st March 2021. Nath Bio-Genes (India) Ltd - 537291 - Shareholding for the Period Ended March 31, 2021
Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here